Yantai Zhenghai Bio-Tech Co Ltd

300653 · SHE · Healthcare / Biotechnology

13.67CNY-0.35 (-2.50%)

Price History

Full chart

Market Stats

Previous Close14.02

Open14.02

Day Range13.62 – 14.09

52-Week Range13.37 – 22.96

Volume1.72M

Market Cap2.87B

P/E (TTM)40.87

Forward P/E0.00

EPS0.39

Dividend Yield1.76%

Beta0.03

50-Day Avg14.97

200-Day Avg17.65

About

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral restoration membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etching agent, dental pit and fissure sealant, active biological bone, light-curing composite resin, non-absorbable surgical sutures, and self-etching adhesives. Its products are used in various fields, such as dentistry, orthopedics, neurosurgery, and trauma surgery. Yantai Zhenghai Biotechnology Co., Ltd. was founded in 2003 and is headquartered in Yantai, China.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Kan Song
Employees386
HeadquartersNo. 7 Nanjing Street, Yantai, China, 264006, China
Websitehttps://www.zhbio.com

Leadership

Mr. Kan SongGM & Director · b. 1984
Mr. Donggang ZhangDeputy GM & Employee Representative Director · b. 1976
Ms. Li ZhaoDeputy GM, Secretary & Non-Independent Director · b. 1979
Mr. Xing YangDeputy General Manager · b. 1976
Xiao Ning Sheng ZhangAccounting Supervisor

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	59.30M	77.38M	105.30M	128.13M	150.62M	182.78M	215.54M	279.81M	293.28M	400.18M	433.22M	413.65M	363.23M	364.14M
Growth (%)	-	+30.49%	+36.09%	+21.68%	+17.55%	+21.35%	+17.92%	+29.81%	+4.82%	+36.45%	+8.26%	-4.52%	-12.19%	+0.25%
Cost of Revenue	3.73M	6.25M	7.07M	8.22M	11.41M	12.09M	15.65M	19.72M	23.27M	44.42M	49.87M	42.98M	46.13M	51.43M
Gross Profit	55.56M	71.13M	98.24M	119.91M	139.22M	170.69M	199.89M	260.08M	270.01M	355.75M	383.35M	370.67M	317.09M	312.71M
Gross Margin	93.71%	91.92%	93.29%	93.58%	92.43%	93.39%	92.74%	92.95%	92.07%	88.90%	88.49%	89.61%	87.30%	85.88%
Operating Expense	46.99M	53.55M	66.56M	79.87M	94.58M	100.09M	100.52M	136.59M	136.30M	163.93M	171.28M	152.10M	164.59M	237.11M
Operating Income	8.57M	17.58M	31.67M	40.03M	44.64M	70.60M	99.38M	123.50M	133.71M	191.83M	212.07M	218.57M	152.51M	75.60M
Operating Margin	14.45%	22.72%	30.08%	31.24%	29.63%	38.63%	46.11%	44.14%	45.59%	47.94%	48.95%	52.84%	41.99%	20.76%
EBITDA	13.41M	19.45M	43.37M	53.30M	57.46M	76.12M	104.40M	129.63M	142.67M	209.35M	231.21M	238.92M	174.67M	110.93M
EBITDA Margin	22.61%	25.13%	41.18%	41.60%	38.15%	41.65%	48.43%	46.33%	48.64%	52.31%	53.37%	57.76%	48.09%	30.46%
Net Income	8.52M	15.77M	33.66M	42.49M	45.47M	61.67M	85.82M	107.39M	118.33M	168.55M	185.44M	190.96M	134.64M	82.41M
Net Income Margin	14.36%	20.38%	31.96%	33.16%	30.19%	33.74%	39.81%	38.38%	40.35%	42.12%	42.80%	46.16%	37.07%	22.63%
R&D	-	6.76M	12.49M	13.78M	12.71M	16.42M	16.63M	21.40M	26.57M	35.18M	37.55M	44.05M	39.52M	57.33M
R&D as % of Total Revenue	-	8.73%	11.86%	10.76%	8.44%	8.98%	7.72%	7.65%	9.06%	8.79%	8.67%	10.65%	10.88%	15.74%
Interest Expense	4.76M	-	1.00M	4.29K	5.62K	10.13K	10.89K	28.54K	5.11K	26.16K	17.13K	337.61K	236.85K	11.55K
Interest Expense % of Total Revenue	8.02%	-	0.95%	0.00%	0.00%	0.01%	0.01%	0.01%	0.00%	0.01%	0.00%	0.08%	0.07%	0.00%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	91.78M	77.79M	82.31M	200.35M	259.14M	530.82M	583.98M	720.45M	805.54M	928.92M	986.90M	1.05B	980.11M	984.62M
Total Liabilities	98.21M	48.46M	18.69M	20.95M	30.98M	47.63M	54.99M	132.06M	158.82M	143.65M	121.80M	105.76M	91.33M	95.14M
Total Equity	-6.43M	29.34M	63.62M	179.40M	228.16M	483.18M	529.00M	588.38M	646.72M	785.27M	865.11M	948.07M	888.78M	889.48M
Cash	30.65M	19.61M	19.97M	130.00M	103.73M	98.67M	132.25M	77.70M	193.26M	126.49M	82.49M	76.58M	116.84M	61.99M
Total Debt	86.91M	26.00M	-	-	-	-	-	22.26M	26.37M	13.26M	25.15M	18.01M	5.16M	-
Net Debt	56.26M	6.39M	-19.97M	-130.00M	-103.73M	-98.67M	-132.25M	-55.44M	-166.89M	-113.23M	-57.34M	-76.58M	-116.84M	-

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	22.62M	34.38M	30.79M	45.74M	49.25M	65.47M	77.47M	103.48M	118.43M	166.13M	187.84M	180.48M	151.38M	97.19M
Investing Cash Flow	-3.01M	-502.24K	-3.44M	-5.70M	-75.53M	-262.24M	-3.89M	-109.99M	27.80M	-187.33M	-137.84M	-86.13M	95.66M	-
Financing Cash Flow	6.89M	-44.92M	-27.00M	70.00M	-	191.71M	-40.00M	-48.03M	-60.07M	-30.02M	-105.60M	-108.01M	-193.93M	-
Capital Expenditure	5.41M	3.20M	3.67M	5.81M	35.53M	10.59M	6.77M	62.31M	103.03M	9.82M	56.06M	31.88M	15.57M	9.10M
Free Cash Flow	17.21M	31.18M	27.12M	39.93M	13.72M	54.88M	70.69M	41.17M	15.41M	156.31M	131.78M	148.60M	135.81M	88.09M
Dividends Paid	4.78M	4.00M	1.00M	-	-	40.00M	40.00M	48.03M	60.07M	30.02M	105.60M	108.00M	144.00M	81.71M
FCF to OCF	76.08%	90.68%	88.08%	87.30%	27.86%	83.83%	91.26%	39.78%	13.01%	94.09%	70.16%	82.34%	89.71%	90.64%
Dividend Paid to FCF	27.77%	12.84%	3.70%	-	-	72.88%	56.58%	116.66%	389.94%	19.20%	80.13%	72.68%	106.03%	92.76%

Earnings

Report Date	Aug 1, 2017	Oct 29, 2017	Mar 29, 2018	Apr 26, 2018	Aug 9, 2018	Oct 19, 2018	Feb 27, 2019	Apr 25, 2019	Aug 21, 2019	Oct 23, 2019	Feb 26, 2020	Apr 28, 2020	Aug 4, 2020	Oct 28, 2020	Feb 23, 2021	Apr 28, 2021	Aug 5, 2021	Oct 19, 2021	Mar 1, 2022	Apr 14, 2022	Aug 18, 2022	Oct 24, 2022	Apr 24, 2023	Jul 31, 2023	Oct 23, 2023	Apr 28, 2024	Aug 5, 2024	Oct 22, 2024	Apr 21, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.07	0.10	0.13	0.12	0.10	0.14	0.11	0.15	0.13	0.16	0.23	0.16	0.20	0.22	0.13	0.19	0.21	0.25	0.23	0.31	0.27	0.28	0.17	0.31	0.21	0.24	0.25	0.22	0.05	0.11	0.12	0.08	0.08	0.10
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	-	-	-	-

Key Statistics & Ratios

Market Cap2.87B

Enterprise Value2.19B

Trailing P/E40.87

Forward P/E0.00

Price / Sales8.54

Price / Book3.21

EPS0.39

Book Value4.92

Revenue (TTM)336.07M

Gross Profit (TTM)286.83M

EBITDA78.90M

Profit Margin20.70%

Operating Margin19.71%

Return on Equity8.06%

Return on Assets3.79%

Shares Outstanding180.00M

Shares Float100.89M

Beta0.03

Dividend Yield1.76%

Dividend Rate0.28

Payout Ratio71.85%

Dividends

20261×

0.28May 27, 2026

20251×

0.46May 27, 2025

20241×

0.80Jun 14, 2024

20231×

0.60May 30, 2023

20221×

0.88May 19, 2022

20211×

0.17May 20, 2021

20201×

0.33Jun 5, 2020

20191×

0.27May 15, 2019

20181×

0.22May 15, 2018

Stock Splits

May 19, 20221.5:1
Jun 5, 20201.5:1